Covid-19 crisis: Bharat Biotechs vaccine gets nod for human trials

  • Covid-19 crisis: Bharat Biotechs vaccine gets nod for human trials

Covid-19 crisis: Bharat Biotechs vaccine gets nod for human trials

"Our collaboration with ICMR and NIV has been instrumental in this development".

The agency would require drugmakers to show "clearly demonstrated" proof of a vaccine's safety and effectiveness through a clinical study, and at least 50 percent more effectiveness than a placebo, the Wall Street Journal report said.

Explaining why the firm advanced its clinical trials by two months, Stoffels said, "Based on the strength of the preclinical data we have seen so far and after interacting with the regulatory authorities, we are able to accelerate the clinical development of our investigational SARS-CoV-2 vaccine candidate".

The Chinese government has approved the use of an experimental COVID-19 vaccine for the country's military - the latest step in a global race to stop the deadly disease caused by the novel coronavirus. The proactive support and guidance from the CDSCO has enabled approvals to this project.

But vaccines against viruses are extremely hard to develop, and a "gold standard" preventor - one that lasts six months, is at least 50 per cent effective and can successfully prevent transmission of the virus - will no doubt take time. "We worked tirelessly to deploy our proprietary technologies towards this platform".

China first announced it had been permitted to test its potential Covid-19 vaccine on humans last week. The vaccine candidate was developed jointly by CanSino and a research institute at the Academy of Military Science (AMS).

Of these 16 vaccine candidates, five are being researched in China, three in the U.S., two in the United Kingdom, and one each in Australia, Germany, and Russian Federation.

While there are multiple vaccine trials ongoing in India, including those of candidates by Zydus Cadila, Serum Institute of India and Panacea Biotec, all of them are in pre-clinical stage as of now. Yet, a cure for COVID-19 has not been found. CNBG said on Tuesday it will run a Phase 3 for its vaccine candidate in the United Arab Emirates, without specifying which shot will be tested.

As on June 28, a total of 548k cases have been registered across India and 16475 people have died.

China reported 12 new confirmed Covid-19 cases as ofSunday, down from 17 reported a day earlier, the country's National Health Commission said yesterday. The Ministry of Home Affairs has releases Unlock 2.0 guidelines, which will be in force till 31 July.